I joined MSK as the Therapeutic Medical Physics Residency Program Director in 2024 with the hope of transforming education institutionally and more broadly within the field of medical physics. In this role, I leverage more than a decade of experience developing as a teacher and educational scholar, including two years as residency program director at the University of Nebraska Medical Center. In my teaching, I am a firm believer in evidence-based methods that rely on the learning sciences, but I also emphasize the intrinsic value of each learner and their quality of life.
My clinical activities at MSK currently focus on quality improvement and the implementation of new commercial software tools, and my research interests include bioethics, education research, and dosimetry (including small and nonstandard fields as well as ultra-high dose rate measurements). I lead and participate in multiple national committees in the American Association of Physicists in Medicine related to education, ethics, and the future of medical physics.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Megan Hyun discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures